GlaxoSmithKline (GSK) Stock Research

Friday

Trump Trade: U.S. issues 15% duty on products made from polysilicon

+23

Aug 7, 9:53 AM

Trump admin plans to issue executive order on vaccines, autism, Bloomberg says

Aug 7, 6:30 AM

Over a week ago

GSK closer to relaunching Brexafemme, says Brookline

Jul 31, 11:49 AM

GSK price target raised by 50 GBp at Deutsche Bank

Jul 30, 3:09 PM

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

Jul 29, 10:21 AM

Morning Movers: Corning sinks and Boeing gains after quarterly results

+20

Jul 28, 8:59 AM

GSK initiates 'Accelerate Growth' program

Jul 28, 7:39 AM

GSK sees 70p per share dividend for FY26

Jul 28, 7:36 AM

GSK sees 2031 sales over GBP 40B

Jul 28, 7:35 AM

GSK sees FY26 core EPS growth 7%-9%

Jul 28, 7:35 AM

GSK reports Q2 core EPS 50.5p, up 9% at CER

Jul 28, 7:30 AM

GSK's ViiV Healthcare presents data from Phase IIIb VOGUE study

Jul 27, 1:02 PM

GSK Canada announces approval of Shingrix in prefilled syringe

Jul 24, 6:58 AM

GSK resumed with a Neutral at Citi

Jul 24, 4:18 AM

GSK reports Jideytro approved by FDA for ROS1-positive NSCLC

Jul 22, 12:41 PM

Trump Trade: U.S. to impose 100% tariff on imported generic drugs

+27

Jul 22, 10:06 AM

Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028

+10

Jul 21, 7:01 PM

GSK's ViiV Healthcare to present new data on INSTI-focused portfolio

Jul 21, 9:24 AM

GSK announces EMA accepted submission to update Bexsero label

Jul 20, 6:39 AM

Trevi Therapeutics price target raised by $11 at Clear Street, here's why

Jul 20, 5:21 AM

GSK will not pursue further development of camlipixant in RCC

Jul 17, 6:24 AM

GSK completes acquisition of Nuvalent

Jul 15, 9:41 AM

GSK reports Jemperli single arm trial met its primary objective

Jul 13, 6:42 AM

Federal health role nominee has record of vaccine skepticism, Stat News reports

Jul 10, 3:45 PM

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

Jul 10, 7:07 AM

Robust R&D Pipeline: A strong and focused research and development engine drives future growth and innovation, particularly in immunology, HIV, and infectious diseases.

Specialized Portfolio Focus: A strategic concentration on high-growth areas like specialty medicines and vaccines provides deep expertise and market leadership.

Global Market Penetration: An extensive worldwide presence allows for broad distribution and access to diverse patient populations and markets.

Clinical Development Failure: The failure of investigational drugs in clinical trials can lead to significant write-offs and delayed revenue streams.

Patent Expiry & Generic Competition: The loss of patent exclusivity on key products exposes them to generic competition, causing substantial revenue erosion.

Regulatory Scrutiny & Approval Delays: Strict regulatory environments can lead to delays in drug approvals, additional data requirements, or market restrictions.

Charts

Robust R&D Pipeline: A strong and focused research and development engine drives future growth and innovation, particularly in immunology, HIV, and infectious diseases.

Specialized Portfolio Focus: A strategic concentration on high-growth areas like specialty medicines and vaccines provides deep expertise and market leadership.

Global Market Penetration: An extensive worldwide presence allows for broad distribution and access to diverse patient populations and markets.

Clinical Development Failure: The failure of investigational drugs in clinical trials can lead to significant write-offs and delayed revenue streams.

Patent Expiry & Generic Competition: The loss of patent exclusivity on key products exposes them to generic competition, causing substantial revenue erosion.

Regulatory Scrutiny & Approval Delays: Strict regulatory environments can lead to delays in drug approvals, additional data requirements, or market restrictions.

Friday

Trump Trade: U.S. issues 15% duty on products made from polysilicon

+23

Aug 7, 9:53 AM

Trump admin plans to issue executive order on vaccines, autism, Bloomberg says

Aug 7, 6:30 AM

Over a week ago

GSK closer to relaunching Brexafemme, says Brookline

Jul 31, 11:49 AM

GSK price target raised by 50 GBp at Deutsche Bank

Jul 30, 3:09 PM

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

Jul 29, 10:21 AM

Morning Movers: Corning sinks and Boeing gains after quarterly results

+20

Jul 28, 8:59 AM

GSK initiates 'Accelerate Growth' program

Jul 28, 7:39 AM

GSK sees 70p per share dividend for FY26

Jul 28, 7:36 AM

GSK sees 2031 sales over GBP 40B

Jul 28, 7:35 AM

GSK sees FY26 core EPS growth 7%-9%

Jul 28, 7:35 AM

GSK reports Q2 core EPS 50.5p, up 9% at CER

Jul 28, 7:30 AM

GSK's ViiV Healthcare presents data from Phase IIIb VOGUE study

Jul 27, 1:02 PM

GSK Canada announces approval of Shingrix in prefilled syringe

Jul 24, 6:58 AM

GSK resumed with a Neutral at Citi

Jul 24, 4:18 AM

GSK reports Jideytro approved by FDA for ROS1-positive NSCLC

Jul 22, 12:41 PM

Trump Trade: U.S. to impose 100% tariff on imported generic drugs

+27

Jul 22, 10:06 AM

Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028

+10

Jul 21, 7:01 PM

GSK's ViiV Healthcare to present new data on INSTI-focused portfolio

Jul 21, 9:24 AM

GSK announces EMA accepted submission to update Bexsero label

Jul 20, 6:39 AM

Trevi Therapeutics price target raised by $11 at Clear Street, here's why

Jul 20, 5:21 AM

GSK will not pursue further development of camlipixant in RCC

Jul 17, 6:24 AM

GSK completes acquisition of Nuvalent

Jul 15, 9:41 AM

GSK reports Jemperli single arm trial met its primary objective

Jul 13, 6:42 AM

Federal health role nominee has record of vaccine skepticism, Stat News reports

Jul 10, 3:45 PM

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

Jul 10, 7:07 AM

Company News

Charts

Company News

Charts